SCHEMBL30865070

CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	7/20	0.47

▸	SCTR	P47872	1/20	0.47

▸	CALCR	P30988	4/20	0.47

▸	GRPR	P30550	1/20	0.45

▸	F2	P00734	4/20	0.44

▸	BACE1	P56817	1/20	0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30184074	0.96	CALCR (0.48)	GLP1RSCTRCALCRGRPRF2
SCHEMBL30184234	0.96	CALCR (0.49)	GLP1RSCTRCALCRGRPRBACE1
SCHEMBL30865080	0.93	F2 (0.49)	GLP1RSCTRCALCRF2BACE1
SCHEMBL31622472	0.89	CALCR (0.55)	GLP1RSCTRCALCRF2BACE1
SCHEMBL34460635	0.89	CALCR (0.55)	GLP1RSCTRCALCRF2BACE1
SCHEMBL29798070	0.89	F2 (0.55)	GLP1RSCTRCALCRF2BACE1
SCHEMBL30437302	0.89	CALCR (0.54)	GLP1RSCTRCALCRGRPRBACE1
SCHEMBL30218810	0.89	CALCR (0.48)	GLP1RSCTRCALCRF2BACE1
SCHEMBL31622473	0.88	CALCR (0.55)	GLP1RSCTRCALCRF2BACE1
SCHEMBL29849560	0.88	F2 (0.52)	GLP1RSCTRCALCRF2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240041986-A1	METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF TYPE 1 DIABETES	DR. MARY MORRIS & ASSOCIATES, LLC (US)	2024-02-08	—	—	US	disclosed